Format

Send to

Choose Destination
World J Urol. 2018 Aug;36(8):1335-1336. doi: 10.1007/s00345-017-2153-y. Epub 2017 Dec 18.

Fuhrman grading is inappropriate for papillary renal cell carcinoma.

Author information

1
Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, University of Otago, PO Box 7343, Wellington, New Zealand. brett.delahunt@otago.ac.nz.
2
Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
3
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
4
Aquesta Uropathology and University of Queensland, Brisbane, QLD, Australia.
PMID:
29256019
DOI:
10.1007/s00345-017-2153-y
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center